-
Je něco špatně v tomto záznamu ?
Treatment of adjuvant-induced arthritis with the combination of methotrexate and probiotic bacteria Escherichia coli O83 (Colinfant®)
J. Rovenský, M. Stančíková, K. Švík, J. Utěšený, K. Bauerová, J. Jurčovičová
Jazyk angličtina Země Česko
- MeSH
- antirevmatika aplikace a dávkování MeSH
- artritida experimentální farmakoterapie imunologie terapie MeSH
- Escherichia coli fyziologie MeSH
- financování organizované MeSH
- kombinovaná terapie MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- methotrexát aplikace a dávkování MeSH
- modely nemocí na zvířatech MeSH
- potkani inbrední LEW MeSH
- probiotika aplikace a dávkování MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- mužské pohlaví MeSH
- zvířata MeSH
A certain relationship was observed between the gastrointestinal system, arthritis and immune system. Patients with rheumatoid arthritis have an altered microflora composition and disturbed intestinal defensive barrier. Effect of probiotic bacteria (Colinfant®; COL) with known favorable effect on intestinal microflora was determined on the methotrexate (MTX) treatment of adjuvant arthritis. Rats with adjuvant arthritis were administered methotrexate 0.5 mg/kg body mass 2-times weekly per os, COL 1 mL/kg body mass every second day per os, and a combination of MTX+COL for a period of 28 d from the immunization. Levels of serum albumin, body mass, changes in hind paw swelling, and arthrogram score were estimated in rats as variables of inflammation and destructive arthritis-associated changes. Treatment with MTX, as well as with the combination treatment with MTX+COL significantly inhibited both inflammation and destructive arthritis-associated changes. The combination treatment inhibited both the hind paw swelling and arthrogram score more remarkably than MTX alone; on the other hand, the difference between combination treatment and MTX alone was not significant. Treatment with COL alone had no effect on adjuvant arthritis in rats. Colinfant® can increase the preventive effect of MTX treatment in rat adjuvant arthritis by improving its antiarthritic effects.
Lit.: 27
- 000
- 00000naa 2200000 a 4500
- 001
- bmc09006416
- 003
- CZ-PrNML
- 005
- 20130101215631.0
- 008
- 091231s2009 xr e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Rovenský, Jozef, $d 1943- $7 xx0006668
- 245 10
- $a Treatment of adjuvant-induced arthritis with the combination of methotrexate and probiotic bacteria Escherichia coli O83 (Colinfant®) / $c J. Rovenský, M. Stančíková, K. Švík, J. Utěšený, K. Bauerová, J. Jurčovičová
- 314 __
- $a National Institute of Rheumatic Diseases, Piešťany
- 504 __
- $a Lit.: 27
- 520 9_
- $a A certain relationship was observed between the gastrointestinal system, arthritis and immune system. Patients with rheumatoid arthritis have an altered microflora composition and disturbed intestinal defensive barrier. Effect of probiotic bacteria (Colinfant®; COL) with known favorable effect on intestinal microflora was determined on the methotrexate (MTX) treatment of adjuvant arthritis. Rats with adjuvant arthritis were administered methotrexate 0.5 mg/kg body mass 2-times weekly per os, COL 1 mL/kg body mass every second day per os, and a combination of MTX+COL for a period of 28 d from the immunization. Levels of serum albumin, body mass, changes in hind paw swelling, and arthrogram score were estimated in rats as variables of inflammation and destructive arthritis-associated changes. Treatment with MTX, as well as with the combination treatment with MTX+COL significantly inhibited both inflammation and destructive arthritis-associated changes. The combination treatment inhibited both the hind paw swelling and arthrogram score more remarkably than MTX alone; on the other hand, the difference between combination treatment and MTX alone was not significant. Treatment with COL alone had no effect on adjuvant arthritis in rats. Colinfant® can increase the preventive effect of MTX treatment in rat adjuvant arthritis by improving its antiarthritic effects.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antirevmatika $x aplikace a dávkování $7 D018501
- 650 _2
- $a artritida experimentální $x farmakoterapie $x imunologie $x terapie $7 D001169
- 650 _2
- $a kombinovaná terapie $7 D003131
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a Escherichia coli $x fyziologie $7 D004926
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a methotrexát $x aplikace a dávkování $7 D008727
- 650 _2
- $a probiotika $x aplikace a dávkování $7 D019936
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani inbrední LEW $7 D011917
- 700 1_
- $a Stančíková, Mária, $d 1940- $7 xx0099603
- 700 1_
- $a Švík, Karol $7 xx0119737
- 700 1_
- $a Utěšený, Jaroslav $7 xx0104122
- 700 1_
- $a Bauerová, Katarína. $7 xx0267301
- 700 1_
- $a Jurčovičová, Jana $7 xx0103077
- 773 0_
- $w MED00011005 $t Folia microbiologica $g Roč. 54, č. 4 (2009), s. 359-363 $x 0015-5632
- 910 __
- $a ABA008 $b A 2403 $c 561 $y 8
- 990 __
- $a 20091230090615 $b ABA008
- 991 __
- $a 20130101215817 $b ABA008
- 999 __
- $a ok $b bmc $g 702230 $s 564659
- BAS __
- $a 3
- BMC __
- $a 2009 $b 54 $c 4 $d 359-363 $i 0015-5632 $m Folia microbiologica $x MED00011005
- LZP __
- $a 2009-61/ipme